Multivariate analysis of factors that influence improvement in nonalcoholic fatty liver disease (NAFLD) after pioglitazone treatment.

被引：0
|
作者：
Kawaguchi-Suzuki, Marina [1 ]
Bril, Fernando [2 ]
Orsak, Beverly [3 ]
Ortiz-Lopez, Carolina [3 ]
Lomonaco, Romina [2 ]
Cusi, Kenneth [2 ]
Frye, Reginald [1 ]
机构：
[1] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA
[2] Univ Florida, Coll Med, Div Endocrinol Diabet & Metab, Gainesville, FL USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, San Antonio, TX 78229 USA
来源：
PHARMACOTHERAPY | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
94
引用
收藏
页码：E202 / E202
页数：1
相关论文
共 50 条
  • [1] Role of Genetic Polymorphisms on the Improvement of Liver Histology after Pioglitazone Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Kawaguchi-Suzuki, Marina
    Bril, Fernando
    Cusi, Kenneth
    Langaee, Taimour
    Gong, Yan
    Frye, Reginald
    [J]. HEPATOLOGY, 2014, 60 : 591A - 591A
  • [2] VITAMIN E, PIOGLITAZONE AND DIET THERAPY FOR PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): EVALUATION OF TREATMENT
    Haidarlo, A. Jaafari
    Rashidbeygi, M.
    Ehsanbakhsh, S.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S507 - S507
  • [3] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Ajay Duseja
    Naga Chalasani
    [J]. Hepatology International, 2013, 7 : 755 - 764
  • [4] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Duseja, Ajay
    Chalasani, Naga
    [J]. HEPATOLOGY INTERNATIONAL, 2013, 7 : S755 - S764
  • [5] Factors contributing to nonalcoholic fatty liver disease (NAFLD) and fat deposition after pancreaticoduodenectomy: A retrospective analysis
    Izumi, Hideki
    Yoshii, Hisamichi
    Fujino, Rika
    Takeo, Shigeya
    Nomura, Eiji
    Mukai, Masaya
    Makuuchi, Hiroyasu
    [J]. ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (05): : 793 - 799
  • [6] Nonalcoholic Fatty Liver disease (NAFLD)
    Zeuzem, S.
    Trautwein, C.
    [J]. GASTROENTEROLOGE, 2020, 15 (02): : 77 - 77
  • [7] Pentoxifylline for the treatment of nonalcoholic fatty liver disease (NAFLD): A meta-analysis
    Sy Perillo, Engelbert Simon
    Velasco, Alvin Brian C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 426 - 426
  • [8] OT Texture Analysis in Nonalcoholic Fatty Liver Disease (NAFLD)
    Dichtel, Laura E.
    Tabari, Azadeh
    Mercaldo, Nathaniel D.
    Corey, Kathleen E.
    Husseini, Jad
    Osganian, Stephanie A.
    Chicote, Mark L.
    Rao, Elizabeth M.
    Miller, Karen K.
    Bredella, Miriam A.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (05) : 760 - 766
  • [9] Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Fierbinteanu-Braticevici, Carmen
    Baicus, Cristian
    Tribus, Laura
    Papacocea, Raluca
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2011, 20 (02) : 153 - 159
  • [10] ASSOCIATIONS BETWEEN DIETARY FACTORS AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Kabbara, Khaled W.
    Paik, James M.
    Eberly, Katherine Elizabeth
    De Avila, Leyla
    Henry, Linda
    Younossi, Zobair M.
    [J]. HEPATOLOGY, 2020, 72 : 956 - 957
12345